DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Almirall Agrees Aclidinium Licensing Deal With Menarini Biotech


3/28/2012 7:57:33 AM

Almirall has granted Menarini marketing rights to Aclidinium for the treatment of chronic obstructive pulmonary disease (COPD) in Europe. Under the terms of the deal, Menarini will have joint commercialisation rights to the drug across the majority of EU member states and in other European countries. Almirall will retain sole marketing rights for the product in the UK, the Netherlands and the Nordic countries. Eduardo Sanchiz, chief executive officer of Almirall, explained that Menarini "stood out" among a number of potential partners for the licensing agreement.

Read at News Release

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->